European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

被引：40

作者：

Zinzani, Pier Luigi ^{[1
]}

Karlin, Lionel ^{[2
]}

Radford, John ^{[3
,4
]}

Caballero, Dolores ^{[5
]}

Fields, Paul ^{[6
]}

Chamuleau, Martine E. D. ^{[7
]}

d'Amore, Francesco ^{[8
]}

Haioun, Corinne ^{[9
]}

Thieblemont, Catherine ^{[10
]}

Gonzalez-Barca, Eva ^{[11
]}

Grande Garcia, Carlos ^{[12
]}

Johnson, Peter W. ^{[13
]}

van Imhoff, Gustaaf W. ^{[14
]}

Ng, Thomas ^{[15
]}

Dwyer, Karen ^{[16
]}

Morschhauser, Franck ^{[17
]}

机构：

[1] Univ Bologna, Bologna, Italy

[2] Ctr Hosp Lyon Sud, Pierre Benite, France

[3] Univ Manchester, Manchester, Lancs, England

[4] Christie NHS Fdn Trust, Manchester, Lancs, England

[5] Hosp Univ Salamanca, Salamanca, Spain

[6] Guys Hosp, London, England

[7] Vrije Univ, Med Ctr, Amsterdam, Netherlands

[8] Aarhus Univ Hosp, Aarhus, Denmark

[9] Hop Henri Mondor, Creteil, France

[10] Hop St Louis, Paris, France

[11] Inst Catala Oncol, Barcelona, Spain

[12] Hosp Univ 12 Octubre, Madrid, Spain

[13] Univ Southampton, NIHR CRUK Expt Canc Med Ctr, Southampton, Hants, England

[14] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands

[15] Kyowa Kirin Pharmaceut Dev Inc, Galashiels, Scotland

[16] Kyowa Kirin Pharmaceut Dev Inc, Princeton, NJ USA

[17] Univ Lille 2, Unite GRITA, Lille, France

来源：

HAEMATOLOGICA | 2016年 / 101卷 / 10期

关键词：

aggressive non-Hodgkin lymphoma; mogamulizumab; anti-CCR4 monoclonal antibody; peripheral T-cell lymphoma;

D O I：

10.3324/haematol.2016.146977

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E407 / E410

页数：4

共 11 条

[1] The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells [J].

Campbell, JJ ;

Haraldsen, G ;

Pan, J ;

Rottman, J ;

Qin, S ;

Ponath, P ;

Andrew, DP ;

Warnke, R ;

Ruffing, N ;

Kassam, N ;

Wu, L ;

Butcher, EC .

NATURE, 1999, 400 (6746) :776-780

[2] The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications [J].

Campo, Elias ;

Swerdlow, Steven H. ;

Harris, Nancy L. ;

Pileri, Stefano ;

Stein, Harald ;

Jaffe, Elaine S. .

BLOOD, 2011, 117 (19) :5019-5032

[3] Revised response criteria for malignant lymphoma [J].

Cheson, Bruce D. ;

Pfistner, Beate ;

Juweid, Malik E. ;

Gascoyne, Randy D. ;

Specht, Lena ;

Horning, Sandra J. ;

Coiffier, Bertrand ;

Fisher, Richard I. ;

Hagenbeek, Anton ;

Zucca, Emanuele ;

Rosen, Steven T. ;

Stroobants, Sigrid ;

Lister, T. Andrew ;

Hoppe, Richard T. ;

Dreyling, Martin ;

Tobinai, Kensei ;

Vose, Julie M. ;

Connors, Joseph M. ;

Federico, Massimo ;

Diehl, Volker .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586

[4] Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy [J].

Coiffier, Bertrand ;

Pro, Barbara ;

Prince, H. Miles ;

Foss, Francine ;

Sokol, Lubomir ;

Greenwood, Matthew ;

Caballero, Dolores ;

Borchmann, Peter ;

Morschhauser, Franck ;

Wilhelm, Martin ;

Pinter-Brown, Lauren ;

Padmanabhan, Swaminathan ;

Shustov, Andrei ;

Nichols, Jean ;

Carroll, Susan ;

Balser, John ;

Balser, Barbara ;

Horwitz, Steven .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) :631-636

[5] Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry [J].

Ellin, Fredrik ;

Landstrom, Jenny ;

Jerkeman, Mats ;

Relander, Thomas .

BLOOD, 2014, 124 (10) :1570-1577

[6] CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified [J].

Ishida, T ;

Inagaki, H ;

Utsunomiya, A ;

Takatsuka, Y ;

Komatsu, H ;

Iida, S ;

Takeuchi, G ;

Eimoto, T ;

Nakamura, S ;

Ueda, R .

CLINICAL CANCER RESEARCH, 2004, 10 (16) :5494-5500

[7] Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study [J].

O'Connor, Owen A. ;

Horwitz, Steven ;

Masszi, Tamas ;

Van Hoof, Achiel ;

Brown, Peter ;

Doorduijn, Jeannette ;

Hess, Georg ;

Jurczak, Wojciech ;

Knoblauch, Poul ;

Chawla, Shanta ;

Bhat, Gajanan ;

Choi, Mi Rim ;

Walewski, Jan ;

Savage, Kerry ;

Foss, Francine ;

Allen, Lee F. ;

Shustov, Andrei .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (23) :2492-U21

[8] Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study [J].

O'Connor, Owen A. ;

Pro, Barbara ;

Pinter-Brown, Lauren ;

Bartlett, Nancy ;

Popplewell, Leslie ;

Coiffier, Bertrand ;

Lechowicz, Mary Jo ;

Savage, Kerry J. ;

Shustov, Andrei R. ;

Gisselbrecht, Christian ;

Jacobsen, Eric ;

Zinzani, Pier Luigi ;

Furman, Richard ;

Goy, Andre ;

Haioun, Corinne ;

Crump, Michael ;

Zain, Jasmine M. ;

Hsi, Eric ;

Boyd, Adam ;

Horwitz, Steven .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) :1182-1189

[9] Multicenter Phase II Study of Mogamulizumab ( KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma [J].

Ogura, Michinori ;

Ishida, Takashi ;

Hatake, Kiyohiko ;

Taniwaki, Masafumi ;

Ando, Kiyoshi ;

Tobinai, Kensei ;

Fujimoto, Katsuya ;

Yamamoto, Kazuhito ;

Miyamoto, Toshihiro ;

Uike, Naokuni ;

Tanimoto, Mitsune ;

Tsukasaki, Kunihiro ;

Ishizawa, Kenichi ;

Suzumiya, Junji ;

Inagaki, Hiroshi ;

Tamura, Kazuo ;

Akinaga, Shiro ;

Tomonaga, Masao ;

Ueda, Ryuzo .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (11) :1157-+

[10] Quantifying skin disease burden in mycosis fungoides-type cutaneous T-cell lymphomas - The severity-weighted assessment tool (SWAT) [J].

Stevens, SR ;

Ke, MS ;

Parry, EJ ;

Mark, J ;

Cooper, KD .

ARCHIVES OF DERMATOLOGY, 2002, 138 (01) :42-48

← 1 2 →